Public Employees Retirement Association of Colorado’s Juno Therapeutics, Inc. JUNO Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,492	Closed	-$571K	–	1921
2017 Q4	$571K	Buy	12,492 +1,682	+16%	+$83.9K	﹤0.01%	1066
2017 Q3	$485K	Hold	10,810	–	–	﹤0.01%	1120
2017 Q2	$323K	Buy	10,810 +11	+0.1%	+$271	﹤0.01%	1360
2017 Q1	$240K	Sell	10,799 -25	-0.2%	-$536	﹤0.01%	1487
2016 Q4	$204K	Sell	10,824 -7	-0.1%	-$171	﹤0.01%	1569
2016 Q3	$325K	Buy	10,831 +7	+0.1%	+$218	﹤0.01%	1340
2016 Q2	$416K	Buy	10,824 +1,633	+18%	+$67.8K	﹤0.01%	1192
2016 Q1	$350K	Buy	9,191 +8,808	+2,300%	+$307K	﹤0.01%	1333
2015 Q4	$17K	Buy	383 +3	+0.8%	+$149	﹤0.01%	1872
2015 Q3	$15K	Sell	380 -4	-1%	-$175	﹤0.01%	1902
2015 Q2	$20K	Buy	+384	New	+$20.4K	﹤0.01%	1910

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Public Employees Retirement Association of Colorado's JUNO Position: Q1 2018 in Review

Public Employees Retirement Association of Colorado sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 12,492 shares — an estimated $571K sold.

Public Employees Retirement Association of Colorado first reported a position in JUNO in Q2 2015 and held it in 11 quarters. The position peaked at $571K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Public Employees Retirement Association of Colorado reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Public Employees Retirement Association of Colorado sold 12,492 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $571K.
Public Employees Retirement Association of Colorado first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 11 quarters.
Public Employees Retirement Association of Colorado's Juno Therapeutics, Inc. position peaked at $571K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q1 2018, filed 1 May 2018.